HCA Healthcare (HCA) Q2 2026 — revenue $20.23B (+8.7% Y/Y) and diluted EPS $7.62 (+11.6% Y/Y) beat as same-facility admissions +2.5% and ER visits +3.6%; adj EBITDA $4.03B (+4.6% Y/Y); FY26 guide previously narrowed on July 14 to revenue $77.0–79.5B, adj EBITDA <meta name="viewport" content="width=device-width, initial-scale=1.0" />5.4–16.1B and diluted EPS $28.70–30.50 (from prior $76.5–80.0B / <meta name="viewport" content="width=device-width, initial-scale=1.0" />5.55–16.45B / $29.10–31.50) on $400M payer-mix headwind offset by $400M Medicaid Supplemental Payment benefit

5.4–16.1B and diluted EPS $28.70–30.50 (from prior $76.5–80.0B / 5.55–16.45B / $29.10–31.50) on $400M payer-mix headwind offset by $400M Medicaid Supplemental Payment benefit" /> 5.4–16.1B and diluted EPS $28.70–30.50 (from prior $76.5–80.0B / 5.55–16.45B / $29.10–31.50) on $400M payer-mix headwind offset by $400M Medicaid Supplemental Payment benefit" />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.